Literature DB >> 6751559

Fewer and fewer oncogenes.

R A Weinberg.   

Abstract

Mesh：

Year:  1982        PMID： 6751559     DOI： 10.1016/0092-8674(82)90003-4

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  15 in total

Review 1.  Following the cytokine signaling pathway to leukemogenesis: a chronology.

Authors:  Kendall A Smith; James D Griffin
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

2.  The structure of HSAG-1, a middle repetitive genetic element which elicits a leukemia-related cellular surface antigen.

Authors:  J W Chamberlain; G Henderson; M W Chang; T Lam; D Dignard; V Ling; G B Price; C P Stanners
Journal:  Nucleic Acids Res       Date:  1986-04-25       Impact factor: 16.971

3.  Antitumor therapy based on the use of an immune modulator, arginine butyrate and interferon.

Authors:  C Chany; I Cerutti
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  The predicted DBL oncogene product defines a distinct class of transforming proteins.

Authors:  A Eva; G Vecchio; C D Rao; S R Tronick; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing.

Authors:  John C Castle; Matthew Biery; Heather Bouzek; Tao Xie; Ronghua Chen; Kira Misura; Stuart Jackson; Christopher D Armour; Jason M Johnson; Carol A Rohl; Christopher K Raymond
Journal:  BMC Genomics       Date:  2010-04-16       Impact factor: 3.969

Review 6.  Messenger RNA in regenerating liver: implications for the understanding of regulated growth.

Authors:  N Fausto
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 7.  Progress in visualization of eukaryotic gene transcription.

Authors:  M F Trendelenburg
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Analysis of a transgenic mouse containing simian virus 40 and v-myc sequences.

Authors:  J A Small; D G Blair; S D Showalter; G A Scangos
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

Review 9.  Human oncogenes.

Authors:  K Willecke; R Schäfer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.

Authors:  M Noda; Z Selinger; E M Scolnick; R H Bassin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.